Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Javier Gonzalez

Family Medicine San Antonio, TX Medical Doctor

NPI 1528010212 CMS profile 23722

226 W Bitters Rd, Ste 100, San Antonio, TX 78216

Open in the dashboard

General payments

$6,364

376 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$641,471 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Javier Gonzalez of San Antonio, TX is reported in the CMS Open Payments database as having received $6,364 across 376 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $641,471 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $550 37
2024 General $591 48
2023 General $753 52
2022 General $921 41
2021 General $1,556 67
2020 General $805 49
2019 General $1,188 82

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Javier Gonzalez
  • Family Medicine median
  • Middle half of Family Medicine
  • National median

In program year 2025, general payments to Javier Gonzalez were reported at $550. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.

Show as a table
Year Javier Gonzalez Family Medicine median Middle half National median
2019 $1,188 $150 $41–$543 $163
2020 $805 $120 $32–$415 $114
2021 $1,556 $137 $35–$551 $132
2022 $921 $137 $37–$512 $149
2023 $753 $149 $42–$545 $160
2024 $591 $156 $44–$560 $164
2025 $550 $155 $45–$549 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $960 41 payments
  2. Biohaven Pharmaceuticals, Inc. $716 3 payments
  3. AstraZeneca Pharmaceuticals LP $701 19 payments
  4. Lilly USA, LLC $665 46 payments
  5. Pfizer Inc. $627 77 payments
  6. Amarin Pharma Inc. $499 32 payments
  7. Biohaven Pharmaceutical Holding Company Ltd. $445 16 payments
  8. AbbVie, Inc. $355 33 payments
  9. Allergan Inc. $299 42 payments
  10. Arbor Pharmaceuticals, Inc. $198 15 payments
  11. Other $900 52 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,350 375 payments
  2. Education $14 1 payment
Products named General payments · program years 2019–2025
  1. NURTEC ODT Primary Care $1,160 19 payments
  2. JARDIANCE $701 30 payments
  3. MOUNJARO $592 38 payments
  4. FARXIGA $561 10 payments
  5. Vascepa $459 30 payments
  6. ELIQUIS $369 44 payments
  7. NURTEC ODT Pain $315 38 payments
  8. UBRELVY $303 30 payments
  9. SYNJARDY $297 13 payments
  10. SYMBICORT $292 5 payments
  11. Other $3,138 242 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

376 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Family Medicine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record